S&P Futures
4,183.50 +59.00 (+1.43%) Dow Futures
33,091.00 +354.00 (+1.08%) Nasdaq Futures
13,290.75 +259.25 (+1.99%) Russell 2000 Futures
1,941.20 +26.60 (+1.39%) Crude Oil
89.91 -0.59 (-0.65%) Gold
1,822.30 +10.00 (+0.55%)
Bio-Rad Laboratories, Inc. (BIO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 535.08 |
| Open | 533.00 |
| Bid | 438.72 x 1100 |
| Ask | 0.00 x 800 |
| Day's Range | 516.28 - 533.00 |
| 52 Week Range | 462.61 - 832.70 |
| Volume | |
| Avg. Volume | 178,569 |
| Market Cap | 15.517B |
| Beta (5Y Monthly) | 0.93 |
| PE Ratio (TTM) | 2.35 |
| EPS (TTM) | 220.48 |
| Earnings Date | Apr 27, 2022 - May 02, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 690.00 |
- Insider Monkey
12 Best Healthcare Stocks To Buy Now
In this piece, we will take a look at the twelve best healthcare stocks to buy now. If you want to skip the details and head on to the top stocks in this list, then take a look at 5 Best Healthcare Stocks To Buy Now. Healthcare stocks are proving to be resilient in the […]
- Business Wire
Bio-Rad Acquires Curiosity Diagnostics
HERCULES, Calif., August 03, 2022--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE NewConnect: SCP), a Warsaw, Poland, based developer of innovative technology solutions for the medical diagnostic and healthcare markets, for a total consideration of up to $170 mil
- Zacks
Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Gross Margin Up
Overall demand for Bio-Rad's (BIO) Life Science and Clinical Diagnostics continues to be strong on localized surges of COVID-19.
